•
AC
ACON
Aclarion, Inc. Common Stock
polygonSERVICES-MEDICAL LABORATORIES
--
Price Chart
Market Cap
4.06M
Volume
96.08K
52W High
$692.85
52W Low
$3.68
Open
$3.83
Prev Close
$3.85
Day Range
3.81 - 4.00
About Aclarion, Inc. Common Stock
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Latest News
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
Benzinga•Jan 13
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
GlobeNewswire Inc.•Jan 13
Aclarion Provides 2025 Update and 2026 Corporate Outlook
GlobeNewswire Inc.•Jan 8
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
GlobeNewswire Inc.•Jan 6
Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
GlobeNewswire Inc.•Oct 22
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
GlobeNewswire Inc.•Oct 13
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
GlobeNewswire Inc.•Oct 7
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
GlobeNewswire Inc.•Sep 25